Loading clinical trials...
Loading clinical trials...
Neurofibromatosis type 1 (NF1), a genetic disorder, results from NF1 gene mutations with nearly complete penetrance (1). NF1 is considered common as a rare disease; it has a birth incidence of approxi...
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
AstraZeneca Clinical Study Information Center
CONTACT
1-877-240-9479information.center@astrazeneca.comLead Sponsor
AstraZeneca
NCT03050268 · Acute Leukemia, Adenomatous Polyposis, and more
NCT06541847 · Neurofibromatosis Type 1
NCT06507748 · Neurofibromatosis Type 1
NCT03871257 · Low Grade Glioma, Neurofibromatosis Type 1, and more
NCT03190915 · Juvenile Myelomonocytic Leukemia, Neurofibromatosis Type 1
Research Site
Al Mansurah
Research Site
Alexandria
Research Site
Aswān
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions